| AKRO Average Annual Return Chart Since 2019 | |||
Also see: • AKRO stock yearly return 2020 • AKRO stock yearly return 2021 • AKRO stock yearly return 2022 • AKRO stock yearly return 2023 • AKRO YTD return | |||
| Average Annual Return Benchmarks |
|
Compare AKRO average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| AKRO Share Performance |
| AKRO Average Annual Return Table Since 2019 | ||||||||||||||||||||||||||||||
AKRO average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About Akero Therapeutics Inc |
| Akero Therapeutics is a clinical-stage company developing treatments for patients with serious metabolic diseases, including non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. NASH is a severe form of nonalcoholic fatty liver disease characterized by inflammation and fibrosis in the liver that can progress to cirrhosis, liver failure, cancer and death. Co.'s primary product candidate, efruxifermin, is an analog of fibroblast growth factor 21, which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates and proteins throughout the body. The AKRO average annual return since 2019 is shown above.
The Average Annual Return on the AKRO average annual return since 2019 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether AKRO average annual return since 2019 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the AKRO average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| AKRO Current Stock Quote |
 Free AKRO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| Akero Therapeutics (AKRO) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
AKYA Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!